Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

16.05
BATS BZX Real-Time Price
As of 11:01am ET
 -0.60 / -3.60%
Today’s Change
4.15
Today|||52-Week Range
18.30
+202.83%
Year-to-Date
No recent news for Ignyta Inc.

Today’s Trading

Previous close16.65
Today’s open16.55
Day’s range15.90 - 16.55
Volume154,498
Average volume (3 months)1,069,779
Market cap$936.6M
Dividend yield--
Data as of 11:01am ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)+21.80%
Earnings growth (this year)+4.37%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book7.32

Competitors

 Today’s
change
Today’s
% change
ADAPAdaptimmune Therapeu...-0.02-0.28%
MCRBSeres Therapeutics I...-0.20-1.94%
AMAGAMAG Pharmaceuticals...-0.40-2.49%
ANIPANI Pharmaceuticals ...-0.35-0.59%
Data as of 11:01am ET, 10/20/2017

Financials

Next reporting dateNovember 7, 2017
EPS forecast (this quarter)-$0.54
Annual revenue (last year)$0.00
Annual profit (last year)-$103.6M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Jonathan E. Lim
Chief Operating Officer
Zachary Hornby
Corporate headquarters
San Diego, California

Forecasts